proline has been researched along with Agnogenic Myeloid Metaplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bui, LA; Clary, DO; Cortes, J; Kantarjian, H; Olszynski, P; Shah, NP; Smith, CC; Sokol, L; Song, C; Tam, CS; Verstovsek, S; Wadleigh, M | 1 |
| Berk, PD; Popper, H | 1 |
| Fujisaki, Y; Kohgo, Y; Mahara, K; Mogi, Y; Niitsu, Y; Ogura, M; Saito, H; Terui, T; Urushizaki, Y; Watanabe, N | 1 |
1 review(s) available for proline and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Lessons from the study of cirrhosis and other fibrotic diseases of the liver.
Topics: Basement Membrane; Cell Communication; Collagen; Connective Tissue; Extracellular Matrix; Glycoproteins; Humans; Inflammation; Kinetics; Liver; Liver Cirrhosis; Primary Myelofibrosis; Proline | 1984 |
1 trial(s) available for proline and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Drug Monitoring; Early Termination of Clinical Trials; Female; Humans; Janus Kinase 2; Male; Middle Aged; Neurotoxicity Syndromes; Primary Myelofibrosis; Proline; Protein Kinase Inhibitors; Pyrimidines | 2014 |
1 other study(ies) available for proline and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Cell Aggregation; Cell Line; Collagen; Fibroblasts; Humans; Leukemia; Leukemia, Megakaryoblastic, Acute; Primary Myelofibrosis; Proline; Rats; RNA, Messenger; Transforming Growth Factors; Tumor Cells, Cultured | 1990 |